MICHELLE WANDS: Open Payments
NPI 1568044287 · DAVIDSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 57 payments from 11 companies in 2025. Trend: 2023 $1,121 · 2024 $1,183 · 2025 $1,397
Food & beverage: $1,397
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $375 |
| UCB, Inc. | 10 | $268 |
| Amgen Inc. | 11 | $210 |
| Janssen Biotech, Inc. | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| ABBVIE INC. | 3 | $73 |
| Mallinckrodt Hospital Products Inc. | 3 | $67 |
| Lilly USA, LLC | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 2 | $43 |
Products named: SAPHNELO, Bimzelx, OTEZLA, TREMFYA, COSENTYX, ORENCIA, SKYRIZI, ACTHAR.
Industry payments across NC — which companies pay providers there.
